Table 2.
Cochrane Collaboration’s tool risk-of-bias assessment for the clinical outcomes (hemoglobin A1c and self-monitoring blood glucose changes) of the included study papers.
|
|
Castensøe-Seidenfaden [12] | Cafazzo [13] | Goyal [14] | Kirwan [15] | Clemens [16] | Ryan [17] |
| Random sequence generation | Low | High | Low | Low | High | High |
| Allocation concealment | Low | High | Low | Low | High | Low |
| Blinding of participants and personnel | N/Aa | N/A | N/A | N/A | N/A | N/A |
| Blinding of outcome assessment | Low | High | High | Low | High | Unclear |
| Incomplete outcome data | Low | Low | Low | High | Low | Low |
| Selective reporting | Low | Low | Low | High | Low | Low |
| Other bias | Low | Unclear | Low | Unclear | Unclear | Low |
aN/A: not applicable (both patient and doctors know the group they are allocated).